JBIO
Jade Biosciences, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.21B
P/E Ratio
—
EPS
$-3.19
Beta
—
52W High
$28.00
52W Low
$6.57
50-Day MA
$17.36
200-Day MA
$12.63
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Jade Biosciences, Inc.
Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company is headquartered in Waltham, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-113.52M |
| Operating Margin | 0.00% |
| Return on Equity | -89.20% |
| Return on Assets | -33.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.74 |
| Price-to-Book | 3.59 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $49.35M |
| Float | $32.70M |
| % Insiders | 1.12% |
| % Institutions | 101.63% |
Historical Volatility
HV 10-Day
121.12%
HV 20-Day
99.52%
HV 30-Day
94.59%
HV 60-Day
75.88%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($30.14 target)
9
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026